Avulux—the world's only clinically proven lens that blocks the harmful light wavelengths linked to migraine attacks—and Eyenavision partnered to launch Chemistrie Avulux, a new eyeglass clip for people who live with migraines and light sensitivity.
Millions of people are impacted by migraines and experience life disruptions as a result of symptoms like severe headaches, nausea and visual disturbances. This complex genetic neurological disorder is often worsened by light, and the innovative Chemistrie Avulux clips are an on-demand solution that builds on the light filtration properties of Avulux. These eyewear clips block up to 97% of harmful blue, amber and red lightwaves linked to triggering or worsening migraine attacks, and let in soothing green light.
Migraine-Soothing Eyewear Clips
Chemistrie Avulux Eases the Discomfort of Light Sensitivity
Trend Themes
-
Migraine Management Tech — New innovations like Avulux's eyewear clips offer targeted relief for individuals suffering from light-sensitive migraines, emphasizing personalized healthcare solutions.
-
Wearable Health Devices — Chemistrie Avulux's on-demand eyeglass clips exemplify the increasing integration of health solutions into everyday fashion accessories.
-
Blue Light Filtering — Advanced eyewear like Chemistrie Avulux shows the beneficial impact of filtering harmful light wavelengths to alleviate migraine symptoms.
Industry Implications
-
Optical Industry — The partnership between Avulux and Eyenavision reveals opportunities in developing specialized lenses for health and wellbeing.
-
Healthcare Technology — Innovative products like migraine-soothing eyewear clips demonstrate the fusion of medical research and consumer health tech.
-
Consumer Electronics — The increased demand for blue light filtering solutions underscores the potential for growth in consumer electronics focusing on health benefits.